Masimo (MASI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Masimo Corporation (Nasdaq: MASI), a leading global medical innovator, today announced the appointments of Timothy J. Scannell and Wendy E. Lane to the Company’s Board of Directors (the "Board"), ...

Masimo has expanded the board with the addition of former Stryker President Timothy Scannell and Lane Holdings Chair Wendy ...

Piper Sandler analyst Jason Bednar maintained a Buy rating on Masimo (MASI – Research Report) today and set a price target of $165.00.

IRVINE, Calif. - Masimo (NASDAQ:MASI) Corporation (NASDAQ:MASI), known for its medical technology innovations, has appointed Timothy J. Scannell and Wendy E. Lane to its Board of Directors.

Irvine-based Masimo Corp. announced it has added Timothy Scannell and Wendy Lane to its board of directors, effective ...

Irvine, CA-based Masimo Corporation develops ... Momentum investors should take note of this Medical stock. MASI has a Momentum Style Score of A, and shares are up 25.2% over the past four ...

Pulse oximeters may provide inaccurate oxygen level readings for people with darker skin tones. The FDA plans to issue new ...

Correction: An earlier version of this article incorrectly identified the Canadian city where Grenfell Ministries started an ...

Before buying an Apple Watch, consider key factors like OS superiority, thoughtful features, strong privacy protections, and ...

The patient was in his 60s, an African American man with emphysema. The oximeter placed on his fingertip registered well ...

Chopra covers the Healthcare sector, focusing on stocks such as Masimo, Conmed, and Alphatec Holdings ... Conmed (CNMD) Company Description: CONMED Corp. operates as a medical technology company, ...